Article Information
History
- April 26, 2023.
Article Versions
- Version 1 (September 17, 2022 - 10:28).
- Version 2 (September 21, 2022 - 07:01).
- Version 3 (January 27, 2023 - 14:00).
- You are viewing Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Brian Sullivana,**,
- Edward Barkera,
- Philip Williamsc,
- Louis MacGregora,
- Ranjeet Bhambera,
- Matt Thomasb,
- Stefan Gurneyc,
- Catherine Hyamsa,b,
- Alastair Whitewayb,
- Jennifer A Coopera,
- Chris McWilliamsa,
- Katy Turnera,
- Andrew W. Dowseya,* and
- Mahableshwar Alburb,*,**
- aUniversity Of Bristol
- bSouthmead Hospital, North Bristol NHS Trust
- cUniversity Hospitals Bristol and Weston NHS Trust
- ↵**Corresponding authors Email address: brian.sullivan{at}bristol.ac.uk,mahableshwar.albur{at}nbt.nhs.uk (Mahableshwar Albur)
Posted April 26, 2023.
Conventional and Bayesian workflows for clinical prediction modelling of severe Covid-19 outcomes based on clinical biomarker test results: LabMarCS: Laboratory Markers of COVID-19 Severity - Bristol Cohort
